Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1448, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin + epirubicin is active in the treatment of metastatic germ cell cancer

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin

By Sun X-C Lin J Ju A-H

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2096-2102

Field House Publishing

Access to resources Recommend Favorite

Edatrexate [10 EDAM] shows relatively moderate activity in the treatment of metastatic breast cancer, but is well tolerated

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Docetaxel shows antitumour activity when used as neoadjuvant chemotherapy in cervical cancer

Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite